Medical Marijuana For Cancer Patients And Everything In Between

Posted On November 30, 2020December 1, 2020

Antiquated practices worldwide used marijuana to spread medicinal and recreational purposes. Lots of examples are found by archaeologists and historians during the examination of old documents and artifacts. For instance, the traditional Egyptian Ebers Papyrus is the original complete preserved medical documents, dating back to the eighteenth-century B.C. It documents the elements and preparation of medicinal remedies employed by the traditional Egyptians. It includes various recipes containing marijuana for ailments, including inflammation and pain.

Medical Marijuana In Ancient Times

In Ancient China, legend has it that Emperor Shen Neng (c. 2737 B.C.) prescribed teas made up of medicinal marijuana for a spread of illnesses and therefore, the first documented use of marijuana as an analgesic was registered in 140-208 in China by the surgeon Hua Tao, who prescribed his patients a powdered extract of the plant combined with wine before surgery.

Medicinal Marijuana For Cancer

In the context of cancer, while the prescribed use of medicinal marijuana for cancer is comparatively unique to Oncologists in current times, its origins go back thousands of years. In 1993, the mummified remains of a girl, estimated to be a minimum of 2,500 years old, were found within the Altai Mountains of Siberia. Amongst the things placed in her grave, archaeologists found a pouch of marijuana, known to be an analgesic in the past.

Moreover, a study of the remains by MRI revealed that the lady had been affected by high-level metastatic carcinoma. The researchers hypothesize that the lady used marijuana to supply relief from her illness’s pain and symptoms. That explains why there has also been an increase in grandaddy purple feminized seeds in the market, leading to more medical cannabis supply.

Clinical Practice In Modern Approach

The pharmaceutical industry is developing drugs supported by active components of marijuana. Two medications are currently approved in several nations for cancer-related pain:

• Dronabinol (synthetic Δ9-tetrahydrocannabinol -THC- the primary psychoactive cannabinoid found in marijuana)
• Sativex (a mixture of the leaf and flower of two strains of marijuana, cultivated with controlled THC and Cannabidiol) proportions.

Not surprisingly, most of the clinical test evidence supporting the utilization of marijuana for cancer patients comes from those drugs’ event processes instead of trials with the botanical. Since clinicians rely heavily on clinical test data, some remain skeptical about the effectiveness of medicinal marijuana.

Medical Marijuana Research For Cancer

Modern research, in two peer-reviewed papers directed at medical professionals, Oncologist Dr. D.I. Abrams at the University of San Francisco caused a compelling discussion for medicinal marijuana in modern clinical cancer care protocols. Dr. Abrams argued that while the evidence from clinical trials of the botanical in controlled conditions is often lacking or inconclusive, clinical practice experience demonstrates that it helps patients dealing with cancer and improves their quality of life.

The Doctor primarily supports the utilization of medicinal marijuana for welfare from chemotherapy-induced neuropathic pain, insomnolence, vomiting, and loss of appetite when traditional treatments have failed and when side effects of pharmaceutical outweigh the drugs’ advantages.

Cannabinoids And Cancer

The complex molecular mechanisms behind the cannabinoid activity are still unraveled, although the CB1 receptor is assumed to be involved. This research is now advancing towards clinical studies. There are several other exciting preclinical data samples in different tumor types; the research is reviewed intimately within the following publication. This research remains at the early stages and wishes to be translated into humans; however, the longer-term of marijuana within the field of Oncology certainly looks promising.

For example, in laboratory studies of glioma cells, cannabinoids were shown to induce necrobiosis (apoptosis) and stop cell growth (proliferation). These activities were also observed in rat and mouse models, and reductions in tumor sizes were recorded.

Conclusion

Given the data from clinical practice, there is a transparent data need from extensive clinical studies of medicinal marijuana to support its use in cancer patients for alleviating the symptoms related to cancer. However, the herbal may hold the key to quite just symptomatic relief. There is a growing body of evidence from preclinical research in cell and animal models that suggest that many active components of marijuana may have direct antitumor activity. One can also buy blueberry jack herer autoflower seeds and extract cannabinoid at the comfort of their home.